Access the full text.
Sign up today, get DeepDyve free for 14 days.
T. Cai, S. Mazzoli, F. Meacci, G. Nesi, P. Geppetti, G. Malossini, R. Bartoletti (2011)
Human papillomavirus and non-muscle invasive urothelial bladder cancer: potential relationship from a pilot study.Oncology reports, 25 2
E. Ghasemian, S. Monavari, G. Irajian, Mohammad Nodoshan, R. Roudsari, Y. Yahyapour (2013)
Evaluation of human papillomavirus infections in prostatic disease: a cross-sectional study in Iran.Asian Pacific journal of cancer prevention : APJCP, 14 5
Study of relationship among CD 82 and hTERT protein expression , HPV infection and penile cancer
Chu-Yi Liu, Fan Li, Yi Zeng, M. Tang, Yulu Huang, Jin-Tao Li, Ru-gang Zhong (2015)
Infection and integration of high-risk human papillomavirus in HPV-associated cancer cellsMedical Oncology, 32
W. Dong (2006)
A diagnosis value study of the gene expression of human papillomavirus (HPV) 16/18 E_7 in urine cast-off cells of transitional cell bladder cancer
(2003)
Relationship between HPV and bladder cancer biological behavior
J. Bae (2015)
Human papillomavirus 16 infection as a potential risk factor for prostate cancer: an adaptive meta-analysisEpidemiology and Health, 37
K. Stratton, D. Culkin (2016)
A Contemporary Review of HPV and Penile Cancer.Oncology, 30 3
G. Kondoh, Y. Murata, K. Aozasa, M. Yutsudo, A. Hakura (1991)
Very high incidence of germ cell tumorigenesis (seminomagenesis) in human papillomavirus type 16 transgenic miceJournal of Virology, 65
H. Strickler, M. Schiffman, K. Shah, C. Rabkin, J. Schiller, S. Wacholder, B. Clayman, R. Viscidi (1998)
A survey of human papillomavirus 16 antibodies in patients with epithelial cancersEuropean Journal of Cancer Prevention, 7
R. Djajadiningrat, E. Jordanova, B. Kroon, E. Werkhoven, J. Jong, D. Pronk, P. Snijders, S. Horenblas, D. Heideman (2015)
Human papillomavirus prevalence in invasive penile cancer and association with clinical outcome.The Journal of urology, 193 2
A. Aghakhani, R. Hamkar, M. Parvin, Nastaran Ghavami, Mahsa Nadri, A. Pakfetrat, M. Banifazl, A. Eslamifar, N. Izadi, S. Jam, Amitis Ramezani (2010)
The role of human papillomavirus infection in prostate carcinomaScandinavian Journal of Infectious Diseases, 43
T. Wiest, E. Schwarz, C. Enders, C. Flechtenmacher, F. Bosch (2002)
Involvement of intact HPV16 E6/E7 gene expression in head and neck cancers with unaltered p53 status and perturbed pRb cell cycle controlOncogene, 21
I. Heidegger, W. Borena, R. Pichler (2015)
The role of human papilloma virus in urological malignancies.Anticancer research, 35 5
Patricia McNICOLl, J. Dodd (1990)
Detection of human papillomavirus DNA in prostate gland tissue by using the polymerase chain reaction amplification assayJournal of Clinical Microbiology, 28
S. Schmid, L. Thümer, T. Schuster, T. Horn, F. Kurtz, J. Slotta-Huspenina, J. Seebach, M. Straub, T. Maurer, M. Autenrieth, H. Kübler, M. Retz, U. Protzer, J. Gschwend, D. Hoffmann (2015)
Human papilloma virus is not detectable in samples of urothelial bladder cancer in a central European population: a prospective translational studyInfectious Agents and Cancer, 10
Samriti Dogra, Sriram Bandi, Preeti Viswanathan, Sanjeev Gupta (2015)
Arsenic trioxide amplifies cisplatin toxicity in human tubular cells transformed by HPV-16 E6/E7 for further therapeutic directions in renal cell carcinoma.Cancer letters, 356 2 Pt B
A. Araujo-Neto, H. Ferreira-Fernandes, Carolina Amaral, L. Santos, A. Freitas, J. Silva-Neto, J. Rey, R. Burbano, B. Silva, F. Yoshioka, G. Pinto (2016)
Lack of detection of human papillomavirus DNA in prostate carcinomas in patients from northeastern BrazilGenetics and Molecular Biology, 39
L. Alemany, A. Cubilla, G. Halec, Elena Kasamatsu, B. Quirós, E. Masferrer, S. Tous, B. Lloveras, G. Hernandez-Suarez, R. Lonsdale, L. Tinoco, M. Alejo, I. Alvarado-Cabrero, J. Laco, N. Guimerà, E. Poblet, L. Lombardi, C. Bergeron, O. Clavero, Hai-rim Shin, A. Ferrera, A. Félix, J. Germar, V. Mandys, C. Clavel, M. Tzardi, L. Pons, V. Wain, E. Cruz, C. Molina, J. Mota, R. Jach, J. Velasco, C. Carrilho, Rubén López-Revilla, M. Goodman, W. Quint, X. Castellsagué, I. Bravo, M. Pawlita, N. Muñoz, F. Bosch, S. Sanjosé (2016)
Role of Human Papillomavirus in Penile Carcinomas Worldwide.European urology, 69 5
K. Shigehara, T. Sasagawa, Shohei Kawaguchi, T. Nakashima, M. Shimamura, Yuji Maeda, H. Konaka, A. Mizokami, Eitetsu Koh, M. Namiki (2011)
Etiologic role of human papillomavirus infection in bladder carcinomaCancer, 117
A. Chen, T. Waterboer, A. Keleher, Beth Morrison, Shalini Jindal, D. McMillan, D. Nicol, R. Gardiner, N. McMillan, A. Antonsson (2011)
Human Papillomavirus in Benign Prostatic Hyperplasia and Prostatic Adenocarcinoma PatientsPathology & Oncology Research, 17
N. Berrada, Abderrahmane Al-Bouzidi, A. Ameur, M. Abbar, M. El-Mzibri, Rabii Ameziane-El-Hassani, L. Benbacer, M. Khyatti, Zineb Qmichou, S. Amzazi, Mohammed Attaleb (2013)
Human papillomavirus detection in Moroccan patients with bladder cancer.Journal of infection in developing countries, 7 8
A. Garolla, D. Pizzol, A. Bertoldo, M. Ghezzi, U. Carraro, A. Ferlin, C. Foresta (2012)
Testicular cancer and HPV semen infectionFrontiers in Endocrinology, 3
K. Anwar, K. Nakakuki, T. Shiraishi, H. Naiki, R. Yatani, Manabu Inzuka (1992)
Presence of ras oncogene mutations and human papillomavirus DNA in human prostate carcinomas.Cancer research, 52 21
Mariarosa Pascale, D. Pracella, R. Barbazza, B. Marongiu, E. Roggero, S. Bonin, G. Stanta (2013)
Is Human Papillomavirus Associated with Prostate Cancer Survival?Disease markers, 35
O. Shaker, O. Hammam, M. Wishahi (2013)
Is there a correlation between HPV and urinary bladder carcinoma?Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 67 3
R. Pichler, W. Borena, G. Schäfer, C. Manzl, Z. Culig, S. List, S. Neururer, D. Laer, I. Heidegger, H. Klocker, W. Horninger, H. Steiner, A. Brunner (2015)
Low prevalence of HPV detection and genotyping in non-muscle invasive bladder cancer using single-step PCR followed by reverse line blotWorld Journal of Urology, 33
AbstractHPV is classified into high-risk and low-risk types depending on its probability of leading to tumorigenesis. Many studies have shown that HPV infection, especially the infection caused by the high-risk type, is always related to prostate cancer, bladder cancer, penile cancer, testicular cancer, and other urinary system tumors. However, previous studies differed in sexual openness and racial genetic susceptibility of the study object, sample size, and experimental methods. Hence, the correlation between high-risk HPV infection and urinary system tumors remains controversial. The early open reading frame of the HPV genome is composed of E1–E7, among which E6 and E7 are the key transfer proteins. The combination of these proteins with oncogene and anti-oncogene may be one of the mechanisms leading to tumorigenesis.
Infection International – de Gruyter
Published: Apr 10, 2018
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.